Peer Review reports
From: Afzelin induces immunogenic cell death against lung cancer by targeting NQO2
| Original Submission | ||
|---|---|---|
| 27 Feb 2023 | Submitted | Original manuscript |
| 20 May 2023 | Reviewed | Reviewer Report |
| 29 May 2023 | Reviewed | Reviewer Report |
| 2 Jun 2023 | Reviewed | Reviewer Report |
| 6 Jun 2023 | Reviewed | Reviewer Report |
| 18 Jul 2023 | Author responded | Author comments - Fang Cao |
| Resubmission - Version 2 | ||
| 18 Jul 2023 | Submitted | Manuscript version 2 |
| 28 Jul 2023 | Author responded | Author comments - Fang Cao |
| Resubmission - Version 3 | ||
| 28 Jul 2023 | Submitted | Manuscript version 3 |
| 31 Jul 2023 | Author responded | Author comments - Fang Cao |
| Resubmission - Version 4 | ||
| 31 Jul 2023 | Submitted | Manuscript version 4 |
| 18 Aug 2023 | Reviewed | Reviewer Report |
| 25 Aug 2023 | Reviewed | Reviewer Report |
| 1 Sep 2023 | Reviewed | Reviewer Report |
| 14 Sep 2023 | Author responded | Author comments - Fang Cao |
| Resubmission - Version 5 | ||
| 14 Sep 2023 | Submitted | Manuscript version 5 |
| 8 Oct 2023 | Reviewed | Reviewer Report |
| 10 Oct 2023 | Reviewed | Reviewer Report |
| 11 Oct 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 15 Oct 2023 | Editorially accepted | |
| 27 Oct 2023 | Article published | 10.1186/s12906-023-04221-3 |
You can find further information about peer review here.